CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Eli Lilly and QurCan sign genetic medicine deal

PartnershipPositive
AI Analysis

Summary

Eli Lilly and QurCan Therapeutics have entered into a partnership to develop genetic medicine for central and peripheral nervous system diseases.

Importance:5/10
Sentiment:
0.30
partnershipgenetic medicineCNSPNS
Related Companies

Read the original article

Published by Pharmaceutical Technology on September 16, 2026 8:25 AM

Read Original